title: Genomic testing and precision medicine--What does this mean for gynecologic oncology?
authors.affiliation: Gynecologic Oncology Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.
authors.forename: Joyce
authors.initials: J
authors.lastname: Liu
authors.affiliation: Gynecologic Oncology Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.
authors.forename: Panagiotis A
authors.initials: PA
authors.lastname: Konstantinopoulos
authors.affiliation: Gynecologic Oncology Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States. Electronic address: ursula_matulonis@dfci.harvard.edu.
authors.forename: Ursula A
authors.initials: UA
authors.lastname: Matulonis
mesh_terms: D005260:Female; D005820:Genetic Testing / Q000379:methods*; D005833:Genital Neoplasms, Female / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D057285:Precision Medicine / Q000379:methods*